The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
Treating populations infected with HIV and latent TB could speed the emergence of drug-resistant TB

Boston, MA -- In 2005, 46 regional Ministers of Health in Africa declared that a dramatic rise in tuberculosis (TB) cases was cause for emergency. In some African countries, annual TB case notifications have increased as much as four-fold over the past 15 years. The main culprit? The emergence of HIV. When individuals are infected with both HIV and TB, they are more likely to progress from latent TB infection to active TB.

To combat the problem, the World Health Organization currently recommends that as part of HIV/AIDS programs, patients infected with both HIV and TB be treated with isoniazid, an antimicrobial, as a preventive therapy to reduce the risk that TB will progress from latent infection to active disease. However, researchers from the Harvard School of Public Health (HSPH) and a team of collaborators believe that strategy has flaws. Their findings appear in the advance online edition of the May 2, 2006 issue of Proceedings of the National Academy of Sciences.

The researchers, led by Ted Cohen, doctoral student at HSPH, and senior author Megan Murray, Assistant Professor of Epidemiology, developed a mathematical model to describe the projected impact of isoniazid preventive therapy (IPT) programs on the transmission dynamics of drug-resistant TB in areas where community-wide preventive therapy may be used as a strategy to control TB. They concluded that the implementation of IPT targeted to people co-infected with HIV and TB may also have the perverse effect of speeding the emergence of drug-resistant TB.

"We're not saying isoniazid preventive therapy policies are ill-advised," said Cohen. "But we think they need to be coupled with an understanding that large-scale IPT programs should be ready to diagnose and treat individuals with drug-resistant TB as part of the programs."


'"/>

Contact: Todd Datz
tdatz@hsph.harvard.edu
617-432-3952
Harvard School of Public Health
17-Apr-2006


Page: 1

Related medicine news :

1. Treating HIV in war zones -- Public health emergencies need rapid advice from WHO
2. Treating prostate cancer in elderly men associated with longer survival, compared to non-treatment
3. AASM position statement: Treating insomnia with over-the-counter sleep aids, herbal supplements
4. Treating medically unexplained symptoms
5. Treating obesity may improve the efficacy of therapy for hepatitis C
6. Treating glaucoma early lowers economic burden
7. Treating gum disease may reduce the risk of cardiovascular disease
8. Treating multiple brain tumors with radiosurgery results in improved survival
9. Treating individuals with substance-abuse disorders who have attempted suicide
10. Treating mental health in general practice
11. Treating autism right the first time

Post Your Comments:
(Date:3/22/2010)... Marketing Capabilities and to Continue Development of Award-winning Controller-less WLAN ... ... (PRWEB) March 22, 2010 -- Aerohive Networks, creators of the ... it has secured $23.5 million in Series C equity funding. ... To date, Aerohive has raised $47.5 million in venture capital ...
(Date:3/22/2010)... target for future treatments, researchers say , , MONDAY, March ... linked with an increased risk for lung cancer in ... team analyzed DNA from more than 1,000 people with ... and found strong evidence that two variations in a ... people who had never smoked. The variations reduce expression ...
(Date:3/22/2010)... at specialized cancer centers, research shows , , MONDAY, March ... patients receive similar care at specialized cancer centers, there ... U.S. study has found. , The finding suggests that ... findings of racial disparities in cancer deaths, the study ... Cancer . , In the study, researchers from ...
(Date:3/22/2010)... that people who chose not to vaccinate put others ... News) -- What began as a family trip to ... nightmare in California. , The family,s 7-year-old boy, who ... virus while traveling in Europe. When he returned home ... 839 people, and an additional 11 unvaccinated children contracted ...
(Date:3/22/2010)... should be getting supplement to meet 400 IU daily ... -- Most infants in the United States aren,t getting ... new federal government report shows. , In 2008, the ... of vitamin D for infants from 200 International Units ... However, too few infants are getting these new levels. ...
Breaking Medicine News(10 mins):Health News:Wireless LAN Innovator Aerohive Secures $23.5 Million Series C Investment 2Health News:Where Cancer Treatment Takes Place May Influence Outcome 2Health News:Measles Outbreak Triggered by Unvaccinated Child 2Health News:Measles Outbreak Triggered by Unvaccinated Child 3Health News:Too Many Infants Short on Vitamin D 2Health News:Too Many Infants Short on Vitamin D 3
(Date:3/22/2010)... Interleukin Genetics, Inc. (NYSE Amex: ILI ) announced today that the ... an extension to meet the Exchange,s continued listing standards and become compliant.  The Company ... by the Exchange staff during the extension period of progress towards the Company,s plan ... ... ...
(Date:3/22/2010)... China , March 22 /PRNewswire-Asia-FirstCall/ -- China Biologic,Products, Inc. ... company in China , today announced that it will,host a conference ... 2010 , to,discuss the fourth quarter and full year 2009 financial results. ... ... ...
(Date:3/22/2010)... ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services today announced that Health Canada-Medical Device Bureau, Therapeutic Products Programme has approved ... ... , ... ... ...
Breaking Medicine Technology:NYSE Amex Provides Interleukin Genetics, Inc. Extension To Meet Continued Listing Standards 2NYSE Amex Provides Interleukin Genetics, Inc. Extension To Meet Continued Listing Standards 3China Biologic Products Schedules Conference Call to Discuss Fourth Quarter and Full Year 2009 Results 2China Biologic Products Schedules Conference Call to Discuss Fourth Quarter and Full Year 2009 Results 3ATS Medical Receives Approval to Commercialize the ATS Simulus Annuloplasty Products in Canada 2ATS Medical Receives Approval to Commercialize the ATS Simulus Annuloplasty Products in Canada 3ATS Medical Receives Approval to Commercialize the ATS Simulus Annuloplasty Products in Canada 4American Society for Microbiology honors Caroline S Harwood 12183 1GenomeQuest Hosting Seminar at ABRF Conference In Sacramento CA 15785 1GenomeQuest Hosting Seminar at ABRF Conference In Sacramento CA 15785 2Gene Sequencing Yields Picture of Human Gut 68073 1Gene Sequencing Yields Picture of Human Gut 68073 2Gene Sequencing Yields Picture of Human Gut 68073 3
Other News:
... LOUIS, JUNE 7, 2005 Prescription drug ... with no year-to-year increase, for sponsors of ... more cost-management programs, according to the 2004 ... cost-management programs adopted by clients of pharmacy ...
... The drug isoniazid reduced the incidence of tuberculosis ... at high risk of TB, according to a ... a theme issue on tuberculosis. ......Lead author Alison ... of Hygiene and Tropical Medicine, London, presented the ...
... Grant has awarded Virginia Tech $119,000 to ... Hepatitis A virus in both shucked and ... Holliman, an M.D. with the High Pressure ... will identify one or more effective high ...
... rooming-in with their babies, even when they think ... in Birth. ......Research supported by the Swedish ... mothers who left their babies in the hospital ... staff believed that was where the babies belonged. ...
health news:Zero increase in prescription drug spending with generic promotion programs 2health news:Zero increase in prescription drug spending with generic promotion programs 3health news:Treatment helps in preventing TB among those at high risk 2health news:Use of high hydrostatic pressure to inactivate Hepatitis A virus in oysters studied 2
... Scientists at Cedars-Sinai Medical Center are seeking ... symptoms associated with the onset of menopause...The ... one of about 17 sites nationwide conducting ... soy-based "phytoestrogens" to moderate the unpleasant symptoms ...
... 28, 1999, GAINESVILLE---A forceful blow to the ... begin gobbling up important structural proteins in ... afterward -- weeks longer than previously suspected, ... Institute researcher...The finding, based on studies in ...
... to zap chronic pain with a single ... to develop toxins that kill only certain ... treatment is substance P-saporin, a toxin that.selectively ... the spinal cord to the.brain.."We have a ...
... .(Revalidation is the answer)...In an editorial, Graham ... for Postgraduate Medical and Dental Education says ... to an acceptance of revalidation. Buckley ... effect on the practice of medicine but ...
health news:Cedars-Sinai researchers participate in study to assess effects of soy-based supplement on symptoms of menopause 2health news:'Biochemical storm' following brain trauma, an important factor in treatment 2health news:'Biochemical storm' following brain trauma, an important factor in treatment 3health news:Targeted toxins may revolutionize pain therapy 2